budesonide 0.25 MG per 2 ML Inhalation Suspension
- RxCUI
- 349094
- RxNorm name
- budesonide 0.25 MG per 2 ML Inhalation Suspension
- Display name
- budesonide 0.25 MG per 2 ML Inhalation Suspension
- Full name
- budesonide 0.25 MG per 2 ML Inhalation Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Budesonide | BUDESONIDE | Rising Pharma Holdings, Inc. | 3235e2a4-8e12-2d58-e063-6294a90a4936 | 2026-07-16 | Warnings, Adverse reactions | 349094 |
| Budesonide Inhalation Suspension | BUDESONIDE | Cipla USA Inc. | c52c5382-1400-44b9-95be-a30e1cf706da | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | American Health Packaging | c7df2a10-4166-423e-bb60-5f3a8234f26c | 2026-05-18 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | Sun Pharmaceutical Industries, Inc. | a39fbcfc-3ffd-44bd-b882-01f8e1844213 | 2026-04-14 | Warnings, Adverse reactions | 349094 |
| Budesonide Inhalation | BUDESONIDE | Preferred Pharmaceuticals Inc. | 1d139a25-9c17-4b3e-8ffd-b2d562cc00ee | 2026-03-20 | Warnings, Adverse reactions | 349094 |
| Budesonide Inhalation | BUDESONIDE | Amneal Pharmaceuticals of New York LLC | e8ef9489-83a2-4817-b21c-ea3fecd8c8dd | 2026-02-02 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | Nephron Pharmaceuticals Corporation | f12043df-f9a3-4edb-88f8-dd176c1a141c | 2025-04-09 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | A-S Medication Solutions | d406759d-4c02-4fc0-b513-56b303afca98 | 2025-02-06 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | A-S Medication Solutions | 521a79d0-4d93-45f7-8feb-8d2b502dd216 | 2024-05-23 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | Chartwell RX, LLC | 374013c9-18c9-4419-b9fb-9bc5c765688e | 2024-02-02 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | A-S Medication Solutions | 32e30f11-e19b-4e23-a893-92d95e48edef | 2023-11-29 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | Teva Pharmaceuticals USA, Inc. | 4f126a29-38f7-4c4c-8978-37e72b289902 | 2021-01-12 | Warnings, Adverse reactions | 349094 |
| Budesonide | BUDESONIDE | Teva Pharmaceuticals USA, Inc. | 2414058b-5d39-42f2-915f-03a5e1101ab5 | 2021-01-12 | Warnings, Adverse reactions | 349094 |
| Budesonide Inhalation Suspension | BUDESONIDE | Exelan Pharmaceuticals, Inc. | d9656442-4587-4867-9a8c-5f5b0402936e | 2020-12-11 | Warnings, Adverse reactions | 349094 |
| PULMICORT RESPULES | BUDESONIDE | AstraZeneca Pharmaceuticals LP | 33cd9834-76df-4f26-3fa2-aab6b9eee8f2 | 2019-10-11 | Warnings, Adverse reactions | 349094 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 33cd9834-76df-4f26-3fa2-aab6b9eee8f2 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 23 | These highlights do not include all the information needed to use PULMICORT RESPULES ® safely and effectively. See full prescribing information for PULMICORT RESPULES ® . PULMICORT RESPULES ® (budesonide) inhalation suspension Initial U.S. Approval: 2000 | 20191011 |
| 2414058b-5d39-42f2-915f-03a5e1101ab5 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 13 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension for inhalation use Initial U.S. Approval: 2000 | 20210112 |
| e8ef9489-83a2-4817-b21c-ea3fecd8c8dd | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 12 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension, for inhalation use Initial U.S. Approval: 2000 | 20260202 |
| c52c5382-1400-44b9-95be-a30e1cf706da | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 12 | These highlights do not include all the information needed to use BUDESONIDE inhalation suspension safely and effectively. See full prescribing information for BUDESONIDE inhalation suspension . BUDESONIDE inhalation suspension . Initial U.S. Approval: 2000 | 20260110 |
| f12043df-f9a3-4edb-88f8-dd176c1a141c | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 8 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE Inhalation Suspension Initial U.S. Approval: 2000 | 20250409 |
| d406759d-4c02-4fc0-b513-56b303afca98 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 6 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 | 20250206 |
| a39fbcfc-3ffd-44bd-b882-01f8e1844213 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 | 20260414 |
| 1d139a25-9c17-4b3e-8ffd-b2d562cc00ee | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension, for inhalation use Initial U.S. Approval: 2000 | 20260320 |
| 4f126a29-38f7-4c4c-8978-37e72b289902 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension for inhalation use Initial U.S. Approval: 2000 | 20210112 |
| d9656442-4587-4867-9a8c-5f5b0402936e | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE INHALATION SUSPENSION. Initial U.S. Approval: 2000 | 20201211 |
| 4830c0dd-6964-4108-89bc-3af039612b95 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 | 20191030 |
| c7df2a10-4166-423e-bb60-5f3a8234f26c | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 3 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 | 20260518 |
| 3235e2a4-8e12-2d58-e063-6294a90a4936 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 2 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE Inhalation Suspension Initial U.S. Approval: 2000 | 20250408 |
| 521a79d0-4d93-45f7-8feb-8d2b502dd216 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 2 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE Inhalation Suspension, for inhalation suspension Initial U.S. Approval: 2000 | 20240523 |
| 32e30f11-e19b-4e23-a893-92d95e48edef | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 2 | These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE inhalation suspension for inhalation use Initial U.S. Approval: 2000 | 20231129 |
| 2e0fa140-85a0-42db-ba15-a068120076b4 | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 2 | These highlights do not include all the information needed to use PULMICORT RESPULES ® safely and effectively. See full prescribing information for PULMICORT RESPULES ® . PULMICORT RESPULES ® (BUDESONIDE INHALATION SUSPENSION) INITIAL U.S. APPROVAL 2000 | 20120604 |
| ca6ae964-3b4b-4c24-a939-0100791ce1fe | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 2 | These highlights do not include all the information needed to use budesonide inhalation suspension safely and effectively. See full prescribing information for budesonide inhalation suspension. BUDESONIDE inhalation suspension Initial U.S. Approval: 2000 | 20120416 |
| 374013c9-18c9-4419-b9fb-9bc5c765688e | budesonide 0.25 MG in 2 ML Inhalation Suspension [PSN] · budesonide 0.125 MG/ML Inhalation Suspension [SCD] · budesonide 0.25 MG per 2 ML Inhalation Suspension [SY] | 3 | 1 | Budesonide Inhalation Suspension These highlights do not include all the information needed to use BUDESONIDE INHALATION SUSPENSION safely and effectively. See full prescribing information for BUDESONIDE INHALATION SUSPENSION. BUDESONIDE Inhalation Suspension, for inhalation suspension Initial U.S. Approval: 2000 | 20240202 |